Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort study

BACKGROUND: Although colonoscopy is the standard screening test for colorectal cancer (CRC), its use is limited by a poor compliance rate, the need for extensive bowel preparation, and the risk of complications. As an alternative, an FDA-approved stool-based DNA test, Cologuard, has demonstrated sat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Fuqiang, Bai, Ping, Xu, Jianfeng, Li, Zitong, Muhammad, Shan, Li, Diange, Zhang, Zeyue, Gao, Yibo, Liu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538018/
https://www.ncbi.nlm.nih.gov/pubmed/37770864
http://dx.doi.org/10.1186/s12943-023-01866-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538018/
https://www.ncbi.nlm.nih.gov/pubmed/37770864
http://dx.doi.org/10.1186/s12943-023-01866-z

Ejemplares similares